These findings show that the PI3K/Akt pathway is associated with Wnt/β-catenin pathway and that SOR + WAY treatment synergistically inhibited the PI3K/Akt and Wnt/β-catenin pathways via regulation of GSK3β in HCC (Fig. 7). The gene discussed is PIK3CA; the disease is hepatocellular carcinoma.